Companies: 10,795·Total market cap: $144.5T
DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Corporation

DMKPQOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$1010
P/E Ratio
52W High$0.001
52W Low$0.00001
Overview

DMK Pharmaceuticals Corporation(DMKPQ)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · DMKPQ · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-9.18dmkpq eps ttm · dmkpq earnings per shareEarnings history
PE Ratio (TTM)dmkpq pe ratio ttm · dmkpq price to earningsPE Ratio deep dive
Revenue (TTM)$3.6Mdmkpq revenue ttm · dmkpq annual revenueFull revenue history
Dividend Yield不分红does dmkpq pay dividends · dmkpq dividend yieldDividend history
Shares Outstanding2.1Mdmkpq shares outstanding · dmkpq floatShares outstanding history
Next EarningsTBAdmkpq earnings date · dmkpq next earningsEarnings history

财务快照

完整财报
FY 2022Revenue$4.8M▲ +115.34% YoY
202020212022
dmk pharmaceuticals corporation revenue · dmkpq revenue 2022
FY 2022Net Income-$26.5M▲ +42.22% YoY
202020212022
dmk pharmaceuticals corporation net income · dmkpq profit 2022
FY 2022EPS$-12.37▲ +44.40% YoY
202020212022
dmkpq eps · dmk pharmaceuticals corporation earnings per share 2022
TTM:Revenue: $3.6MNet Income: -$22.2MEPS: $-9.18View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M-90.00%
YTD+0.71%
1Y+907.14%
5Y-100.00%

关于 DMK Pharmaceuticals Corporation

CEOEddie Wabern Glover
IPO DateAug 14, 1995
Employees11
CountryUS

DMK Pharmaceuticals Corporation a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory …

what is dmk pharmaceuticals corporation · dmkpq stock overview · dmk pharmaceuticals corporation company profile · who is dmk pharmaceuticals corporation ceo · dmkpq OTC · dmk pharmaceuticals corporation headquarters · dmk pharmaceuticals corporation business segments

关于股票概览与关键数据

DMK Pharmaceuticals Corporation(DMKPQ)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Aug 14, 1995 在 OTC 上市。截至最近交易日,DMKPQ 股价为 $0.00,市值约为 $1,010。过去12个月累计回报 +907.14%,年初至今回报 +0.71%。

2022 财年 DMK Pharmaceuticals Corporation 营收 $4.8M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,DMK Pharmaceuticals Corporation(DMKPQ)股价为 $0.00,在 OTC 上市,52周区间为 $0.00 – $0.00。

DMKPQ 最新股价DMKPQ quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议